Whether catheter-directed thrombolysis improves clinical outcomes in patients with intermediate-high–risk pulmonary embolism, ...
Patients are at increased risk for recurrent ischemic events after an acute coronary syndrome event. Milvexian, an oral ...
Approximately one half of patients undergoing transcatheter aortic-valve implantation (TAVI) have concomitant coronary artery ...
Atherosclerosis may begin in early adulthood and remain clinically silent for decades before cardiovascular disease manifests. Although silent atherosclerosis is associated with cardiovascular ...
Pulmonary hypertension that is caused by left heart disease and is associated with heart failure may be driven by sympathetic ...
The effect of clopidogrel monotherapy as compared with extended dual antiplatelet therapy (DAPT) with clopidogrel and aspirin ...
The effectiveness and safety of statins for the primary prevention of cardiovascular events and the extension of disability-free survival among older adults remain uncertain. We conducted a ...
Nonobstructive hypertrophic cardiomyopathy (HCM) is a common condition that is associated with substantial morbidity and no ...
In states with abortion bans, clinicians and hospitals should reduce harm by maximizing care to the extent legally possible, thereby recentering medical expertise and commitment to ...
The safety of omitting up-front treatment with aspirin during primary percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI) remains unclear.
Whether prasugrel or ticagrelor should be the preferred P2Y12 inhibitor for patients with an acute coronary syndrome is uncertain. We conducted a registry-based, open-label, stepped-wedge, ...
Stroke is a severe and common complication of atrial fibrillation. Anticoagulation with vitamin K antagonists or with direct oral anticoagulants (DOACs) prevents the majority of strokes in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results